Latest Share Chat

Glaxosmithkline Share News (GSK)

Glaxosmithkline Information

Buy GSK Shares
Add GSK to Watchlist
Add GSK to Alert

Share Price Information for Glaxosmithkline (GSK)

Share Price is delayed by 15 minutes

Get Live Data

Share Price: 1,775.00

Bid: 1,771.00

Ask: 1,771.50

Change: -8.50 (-0.48%)

Spread: 0.50 (0.028%)

Open: 1,773.50

High: 1,779.00

Low: 1,764.50

Prev. Close: 1,783.50

Last checked at -

UK BROKER RATINGS SUMMARY: Bank Of America Downgrades Morrisons

Mon, 06th Jan 2020 09:37

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning:

----------

FTSE 100

----------

BANK OF AMERICA CUTS WM MORRISON SUPERMARKETS TO 'UNDERPERFORM' ('NEUTRAL')

----------

GOLDMAN SACHS RAISES BP PRICE TARGET TO 750 (730) PENCE - 'CONVICTION BUY LIST'

----------

MORGAN STANLEY RAISES GLAXOSMITHKLINE PRICE TARGET TO 1740 (1640) PENCE - 'UNDERWEIGHT'

----------

MORGAN STANLEY RAISES ASTRAZENECA PRICE TARGET TO 8100 (7400) PENCE - 'EQUAL-WEIGHT'

----------

SOCGEN CUTS NEXT TO 'SELL' ('HOLD') - TARGET 6588 (6301) PENCE

----------

BERNSTEIN RAISES DIAGEO PRICE TARGET TO 3400 (3250) PENCE - 'MARKET-PERFORM'

----------

BARCLAYS RAISES ASHTEAD GROUP PRICE TARGET TO 3195 (2430) PENCE - 'OVERWEIGHT'

----------

JPMORGAN RAISES GLAXOSMITHKLINE PRICE TARGET TO 1900 (1700) PENCE - 'NEUTRAL'

----------

JPMORGAN RAISES ASTRAZENECA PRICE TARGET TO 8500 (7900) PENCE - 'OVERWEIGHT'

----------

JPMORGAN CUTS HIKMA PHARMACEUTICALS TO 'UNDERWEIGHT' ('NEUTRAL') - TARGET 1850 (1800) PENCE

----------

DEUTSCHE BANK RAISES AVIVA PRICE TARGET TO 470 (450) PENCE - 'HOLD'

----------

DEUTSCHE BANK RAISES HARGREAVES LANSDOWN PRICE TARGET TO 1800 (1700) PENCE - 'HOLD'

----------

DEUTSCHE BANK RAISES LEGAL & GENERAL PRICE TARGET TO 335 (290) PENCE - 'BUY'

----------

DEUTSCHE BANK RAISES STANDARD LIFE PRICE TARGET TO 320 (265) PENCE - 'HOLD'

----------

DEUTSCHE BANK CUTS ST JAMES'S PLACE TO 'HOLD' ('BUY') - TARGET 1220 (1190) PENCE

----------

DEUTSCHE BANK RAISES PRUDENTIAL PRICE TARGET TO 1500 (1450) PENCE - 'HOLD'

----------

FTSE 250

----------

UBS RAISES SHAFTESBURY PRICE TARGET TO 915 (860) PENCE - 'NEUTRAL'

----------

UBS RAISES GREAT PORTLAND PRICE TARGET TO 965 (830) PENCE - 'BUY'

----------

UBS RAISES DERWENT LONDON PRICE TARGET TO 4425 (3750) PENCE - 'BUY'

----------

JPMORGAN CUTS ASTON MARTIN LAGONDA PRICE TARGET TO 500 (570) PENCE - 'NEUTRAL'

----------

JEFFERIES RAISES SERCO GROUP PRICE TARGET TO 185 (170) PENCE - 'BUY'

----------

JEFFERIES RAISES MARKS & SPENCER PRICE TARGET TO 230 (207) PENCE - 'HOLD'

----------

JEFFERIES RAISES HAYS PRICE TARGET TO 165 (145) PENCE - 'HOLD'

----------

JEFFERIES CUTS PAGEGROUP TO 'HOLD' ('BUY') - TARGET 555 (540) PENCE

----------

OTHER MAIN MARKET AND AIM

----------

BARCLAYS RAISES JOHNSON SERVICE GROUP TARGET TO 220 (210) PENCE - 'OVERWEIGHT'

----------

DEUTSCHE BANK RAISES JUST GROUP PRICE TARGET TO 70 (54) PENCE - 'HOLD'

----------

JEFFERIES CUTS GAMMA COMMUNICATIONS TO 'HOLD' (BUY) - TARGET 1280 (1320) PENCE

----------

BERENBERG RAISES ON THE BEACH GROUP PRICE TARGET TO 540 (480) PENCE - 'BUY'

----------

BERENBERG RAISES HOLLYWOOD BOWL PRICE TARGET TO 310 (280) PENCE - 'BUY'

----------

More News

18 Sep 2023 07:18

US FDA approves GSK treatment for myelofibrosis

(Sharecast News) - GSK announced on Monday that the US Food and Drug Administration (FDA) has granted approval for 'Ojjaara', or momelotinib, as a treatment for adults suffering from intermediate or high-risk myelofibrosis with anaemia, including cases of primary myelofibrosis or secondary myelofibrosis.

15 Sep 2023 21:52

GSK's Ojjaara approved in US for myelofibrosis patients with anaemia

(Alliance News) - GSK PLC on Friday said Ojjaara, also known as momelotinib, has been approved in the US and the "first and only" treatment indicated for myelofibrosis patients with anaemia.

11 Sep 2023 08:24

Japan accepts GSK's regulatory filing for momelotinib for blood cancer

(Alliance News) - GSK PLC on Monday reported regulatory progress for momelotinib, as Japan's Ministry of Health, Labour & Welfare accepted a review for the blood cancer-focused drug.

11 Sep 2023 07:54

LONDON BRIEFING: Restaurant Group sells Frankie & Benny's and Chiquito

(Alliance News) - Stocks in London are called higher on Monday, ahead of a busy week of interest rate decisions and economic data.

6 Sep 2023 09:32

LONDON BROKER RATINGS: Shore says 'buy' B&M; Peel Hunt likes Halfords

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning:

4 Sep 2023 06:00

More UK babies to need hospital treatment over delay of GSK's RSV jab

(Alliance News) - The nation's top children's doctor has warned a delay on a new vaccine to combat respiratory syncytial virus, or RSV, will mean more babies and infants will need hospital treatment this winter.

1 Sep 2023 09:11

GSK antibody accepted for Japan review, Goldman Sachs reduces stake

(Alliance News) - GSK PLC on Friday said a new drug application for its monoclonal antibody mepolizumab has been accepted for review by the Japanese government.

1 Sep 2023 07:49

LONDON BRIEFING: Stocks seen higher; UK house prices continue to fall

(Alliance News) - Stocks in London are set to open higher on Friday as markets looked ahead to a data-heavy day.

1 Sep 2023 07:12

Japan considering GSK's Nucala drug for sinusitis treatment

(Sharecast News) - Japanese regulators are reviewing a new drug application for GSK's Nucala treatment to be used for the treatment of form of adult sinusitis, the biopharma giant announced on Friday.

23 Aug 2023 12:10

LONDON MARKET MIDDAY: Stocks rise but pound slumps on sub-par UK data

(Alliance News) - Stocks in Europe were on the up heading into Wednesday afternoon, with equity markets in a confident mood on the eve of the Jackson Hole central banking event, shaking off tepid economic data which hurt the pound and euro.

23 Aug 2023 08:17

GSK gets positive results from shingles trial of Shingrix in China

(Alliance News) - GSK PLC on Wednesday celebrated positive results from the first-ever efficacy trial of its preventative shingles treatment, Shingrix, in China.

23 Aug 2023 07:04

GSK reports positive results from shingles vaccine trials in China

(Sharecast News) - GSK reported significant positive findings from its first efficacy trial of the 'Shingrix' shingles vaccine in China on Wednesday.

22 Aug 2023 13:09

UK's Wood Group raises profit forecast on contract wins; shares rise

CFO David Kemp to retire

21 Aug 2023 22:37

US FDA approves Pfizer's maternal RSV vaccine to protect infants

Aug 21 (Reuters) - The U.S. Food and Drug Administration on Monday approved Pfizer's respiratory syncytial virus (RSV) vaccine for use in women during the middle of the third trimester of pregnancy to protect their babies.

17 Aug 2023 19:53

Charity says HIV drug deal with GSK's ViiV on ice over price secrecy

(Alliance News) - The Doctors Without Borders, or MSF, charity said Thursday a deal aimed to bring long-term preventative HIV treatment to vulnerable populations was on hold after the drugmaker imposed pricing confidentiality.

Latest Share Chat

Glaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK BROKER RATINGS SUMMARY: Bank Of America Downgrades Morrisons

Login to your account

Quickpicks are a member only feature

Login to your account